| Jun 24 |
Is Ocugen (OCGN) Stock Outpacing Its Medical Peers This Year?
|
| Jun 24 |
7 A-Rated Penny Stocks to Beat June Gloom
|
| Jun 21 |
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease
|
| Jun 20 |
3 Penny Stocks Set to Make New Millionaires in 2024
|
| Jun 20 |
Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication
|
| Jun 20 |
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
|
| Jun 14 |
7 A-Rated Biotech Stocks Worth Betting on in June
|
| Jun 6 |
Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
|
| Jun 5 |
Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why
|
| May 31 |
(OCGN) - Analyzing Ocugen's Short Interest
|
